This website uses cookies to ensure you have the best user experience. By continuing to use this website, you consent to our use of cookies. For more information, read our privacy policy.
Precision medicine for patients with co-existent ovarian and endometrial cancer: the COMPARE trial
Effect of intravenous iron infusion on the prevention and treatment of anemia in ovarian cancer
Using patient-derived models and drug sensitivity testing to guide personalized medicine: a proof-of-concept trial
Prevalence and Experience of Traumatic Stress in Patients with Newly Diagnosed and Recurrent Advanced Ovarian Cancer
ES2 trial: combining a PARP inhibitor and apoptosis sensitizer
Phase II clinical trial of CX5461 at the time of disease progression on a PARP inhibitor
Re-VOLVE trial: using genomics to make treatment decisions after a PARP inhibitor
Tumour testing and ovarian cancer drug prediction program
